endoluminal solutions, Inc. has entered into an investment agreement with Hong Kong BlueSky Technologies Innovation Limited and held a signing ceremony.
Through this investment, we will accelerate our development activities while promoting business expansion in Japan and other East Asian markets.
Gastric cancer remains a significant health challenge in East Asia. By improving the quality and efficiency of screening, we aim to provide more people with access to appropriate gastric cancer screening.
Through this partnership, we will advance both technological development and real-world implementation while accelerating our growth with a view toward future global expansion.
